Physician profile
Ralph P Crew
NPI 1639281934
$694.30
in general payments reported to CMS, 2019-2025
14 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $28.57 · 2021: $154 · 2022: $44.47 · 2023: $73.21 · 2024: $72.17 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $288.66 | 2021-2025 | Hydrus Microstent |
| Aerie Pharmaceuticals, INC. | $119.56 | 2019 | |
| Abbvie INC. | $57.15 | 2023 | Durysta |
| Johnson & Johnson Surgical Vision, INC. | $36.10 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $34.00 | 2024-2025 | Xiidra |
| Tarsus Pharmaceuticals, INC. | $23.40 | 2025 | Xdemvy |
| Dompe US, INC. | $20.13 | 2024 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $19.62 | 2021 | |
| Amgen INC. | $18.50 | 2024 | Tepezza |
| Lkc Technologies, INC. | $18.34 | 2025 | |
| Biotissue Holdings INC. | $17.54 | 2024 | |
| Ocular Therapeutix, INC. | $16.06 | 2023 | Dextenza |
| Allergan, INC. | $12.85 | 2021 | |
| Sun Pharmaceutical Industries INC. | $12.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Crew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.